Youjin Kim

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC

Youjin Kim, Boram Lee, Joonho Shim et al. · Journal of Thoracic Oncology · 2018 · 187 citations · Full text

Systems Biology, Engineering, Medicine +8

Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor

Youjin Kim, Chu Hyun Kim, Ho Yun Lee et al. · Journal of Thoracic Oncology · 2019 · 104 citations · Full text

Prognostic Biomarkers, Comprehensive Clinical, Medicine +9

Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance

Hee Kyung Kim, Kyung Hee Park, Youjin Kim et al. · Cancer Research and Treatment · 2018 · 100 citations · Full text

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib

Youjin Kim, Se‐Hoon Lee, Jin Seok Ahn et al. · Cancer Research and Treatment · 2018 · 95 citations · Full text

MDSC subtypes and CD39 expression on CD8 ⁺ T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC

Jiae Koh, Youjin Kim, Kyoung Young Lee et al. · European Journal of Immunology · 2020 · 86 citations · Full text